Clinical Trial Detail

NCT ID NCT02133183
Title TORC1/2 Inhibitor INK128 Before and After Surgery in Treating Patients With Recurrent Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

gliosarcoma

glioblastoma multiforme

Therapies

Sapanisertib

Age Groups: adult

No variant requirements are available.